Clasado

Clasado is a leader in next-generation prebiotic galactooligosaccharides (GOS), empowering health and wellbeing globally through their renowned product, Bimuno®. Established in Reading, United Kingdom in 2004, Clasado has nearly two decades of expertise in scientifically supported prebiotic product development. The company has created a substantial impact with their acclaimed ingredient, Bimuno® GOS, which has gained the trust of health and nutrition brands worldwide and is backed by an impressive portfolio of over 120 publications. These publications validate its capacity to enhance health and well-being, particularly in areas such as gastrointestinal, immune, and cognitive health across various applications, including supplements, medical nutrition, functional food, and beverages. The company also offers a range of finished direct-to-consumer prebiotic supplements, such as Bimuno Original, which support better everyday health. The stability, low efficacious daily dose, and availability of health claims in specific geographies make Bimuno GOS an ideal choice for enhancing formulations. As a company operating in the Biotechnology, Health Care, Health and Wellness, and Pharmaceutical industries, Clasado Biosciences presents a compelling case for investment and partnership opportunities.